<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-1171</article-id>
      <article-id pub-id-type="doi">10.51847/DWeXd6w3Ja</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Antipseudomonal, Antioxidant, Anticoagulant, and Cytotoxic Activities of Novel Synthesized Heterocyclic Molecules</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Sakly</surname>
                <given-names>Randa</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Elzletni</surname>
                <given-names>Hend A</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Marzocco</surname>
                <given-names>Stefania</given-names>
              </name>
                              <xref rid="aff3" ref-type="aff">3</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Mastouri</surname>
                <given-names>Maha</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Edziri</surname>
                <given-names>Hayet</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Laboratory of Transmissible Diseases and Biologically Active Substances, Faculty of Pharmacy, University of Monastir 5000, Tunisia.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Biology, Faculty of Education, University of Benghazi, Benghazi, Libya.
          </aff>
                  <aff id="aff3">
            <label>3</label>Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, I-84084, Fisciano, Salerno, Italy.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="jaziri_hayet@yahoo.fr">jaziri_hayet@yahoo.fr</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>30</day>
        <month>01</month>
        <year>2024</year>
      </pub-date>
      <volume>15</volume>
      <issue>1</issue>
      <fpage>103</fpage>
      <lpage>108</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>In this work, we evaluate the antipseudomonal, antioxidant, anticoagulant, and cytotoxic activities of new spirooxindolopyrrolizidine-linked 1,2,3-triazole were investigated for their antipseudomonal, antioxidant, anticoagulant and cytotoxic activities. The antipseudomonal activity of these novel molecules was tested by the microdilution method. DPPH, ABTS, and β-Carotene tests were used to estimate the antioxidant properties. Prothrombin time (PT) and activated partial thromboplastin time (aPTT) tests were measured to evaluate the anticoagulant potential and cytotoxic activity was assessed by MTT test. This study revealed that compounds P3 and P7 displayed excellent antipseudomonal activity against all tested P. aeruginosa Imp/R. with MIC values of 15.62µg/ml. the antioxidant activity demonstrated that all tested heterocyclic compounds exhibited important antioxidant activity by ABTS methods with IC50 ranging between, 25.5 and 35.84µg/ml. In addition, these new compounds were not toxic on the viability of macrophage cells J774A.1 at a concentration of 1 µM and the only non-toxic compound was P7. </p>
      </abstract>
      <kwd-group>
                <kwd>Molecules</kwd>
                <kwd>Heterocyclic</kwd>
                <kwd>Anticoagulant</kwd>
                <kwd>Cytotoxic</kwd>
                <kwd>Antipseudomonal</kwd>
                <kwd>Activities</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>